Syrian Refugee Jihad Alkhaled speaks to a reporter beside his son Mohammad, who suffers from Ewing Sarcoma and would need expensive chemotherapy sessions, in their home in Amman, Jordan, January 29, 2017. REUTERS Video News
SAN FRANCISCO/NEW YORK, (Reuters) - Al Ameen, a 33-year-old Iraqi refugee with hemophilia A, a genetic disorder that prevents proper blood clotting, has been living in Jordan awaiting medical care in the United States for two years. His condition is so advanced, his doctors have told him, that only a handful of facilities in the world can treat him.
Already worried that his application would not be approved in time to get the treatment he needs, the United States' four-month halt of the resettlement of refugees has convinced him he will never be accepted.
Limited time offer:
Just RM5 per month.
